Jackson Andrew C.
- SEC CIK
- 0001636738
No open-market purchases or sales filed in the past year.
Current role at each company
- CLDI Calidi Biotherapeutics, Inc.Chief Financial Officeras of Aug 19, 2026
- ERNA Ernexa Therapeutics Inc.Chief Financial Officeras of Jun 6, 2022
- VTAK Catheter Precision, Inc.CFOas of May 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jackson Andrew C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CLDI Calidi Biotherapeutics, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Jackson Andrew C.Chief Financial Officer | PPurchase | +2.50K | $2.00 | +$5.00K | New position2.50K after | |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Jackson Andrew C.Chief Financial Officer | PPurchase | +2.50K | – | – | –2.50K after | Derivative |
VTAK Catheter Precision, Inc.
CFO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2021 (view filing) | Nov 22 | 2 days | Jackson Andrew C.CFO | SSale | −2.68K | $2.62 | −$7.03K | −10.4%23.0K after |